Aquis Exchange PLC (LON:AQX), the exchange services company, announces that its equities listing division Aquis Stock Exchange (AQSE) has entered into arrangements with Fregnan Ltd and Research Tree Ltd. to produce and publish research on AQSE’s top-tier Apex stocks.

AQSE recognises that research is a very important component of the decision-making process around the purchase and sale of stocks. In recent years, research has been declining, particularly in small and mid-cap stocks.

At the time of its acquisition of AQSE, Aquis stated that one of its aims for the new business was to address this lack of research. Today’s announcement marks a step forward in the fulfillment of that undertaking, as every Apex stock will now have quantitative research, provided by Fregnan, available for free on it through the AQSE website. In addition, any existing fundamental research on Apex stocks will also be available through the new, dedicated, Research Tree portal.

Fregnan produces high quality, unbiased financial analysis and models through automation at scale. It uses advances machine learning and artificial intelligence to bring unique insights that traditional techniques do not uncover. Research Tree is an independent company, which provides investors with up-to-date and historical professional equity research and stock reports from a variety of brokers and research houses.

Commenting on the deal, Aquis Exchange CEO Alasdair Haynes said:

“The plans we are unveiling today for expanding the research provided on AQSE-quoted stocks fulfils yet another of the promises we made when we bought this business and takes us further along the journey of making AQSE into the most appropriate and best home for growth companies. We look forward to a long and fruitful collaboration with both Fregnan and Research Tree.”